Zobrazeno 81 - 90
of 1 541
pro vyhledávání: ''
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 151(1), 41. Springer New York
Breast Cancer Research and Treatment, 151(1), 41. Springer New York
Promoter hypermethylation of tumor suppressor genes seems to be an early event in breast carcinogenesis and is potentially reversible. This makes methylation a possible therapeutic target, a marker for treatment response and/or a prognostic factor. M
Publikováno v:
Breast Cancer Research and Treatment
A mixed methods, community-based research study was conducted to understand how provider-level factors contribute to the African-American and white disparity in breast cancer mortality in a lower socioeconomic status area of North St. Louis. This stu
Autor:
Qiongchao Jiang, Bing Ou, Fengtao Liu, Jiyi Yao, Hui Zhi, Shao-Yun Hao, Xin Pan, Xiao-yun Xiao, Zizhuo Zhao, Bao-Ming Luo
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background There is an unmet need for specific and sensitive imaging techniques to assess the efficacy of breast cancer therapy, particularly Her-2-expressing cancers. Ultrasonic microbubbles are being developed for use as diagnostic and therapeutic
Publikováno v:
Breast Cancer Research and Treatment
Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little a
Autor:
Xavier Gonzalez, Miguel Caballero, Carlos Caso, Albert Biete, Araceli Rodriguez, G. Zanon, Juan J. Grau
Publikováno v:
Annals of Surgical Oncology
Background Many women covered by the Spanish public health system also have an extra private insurance policy for gynecological examinations and routine annual mammography. We retrospectively analyzed the long-term survival rates in these patients wh
Autor:
Oumar Camara, Carola Rabenstein, Cornelia Jörke, Klaus Hoeffken, Ingo B. Runnebaum, Katharina Pachmann, Anne Egbe, U. Hammer
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135(4):643-647
In breast cancers, the gene for the growth factor receptor HER2 can be amplified leading to increased aggressiveness and metastasis formation. The monoclonal antibody trastuzumab prolongs relapse-free survival highly significantly but eventually many
Autor:
Tianfeng Wang, Ai-ping Lu, Yiqiang Liu, Yijun Zhou, Zhaoqing Fan, Tao Ouyang, Yuntao Xie, Jinfeng Li, Yingjian He
Publikováno v:
Breast Cancer Research and Treatment
This study aimed to compare the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Five-hundred and one patients with clinical stage I-III invasive breast cancer were randomly assig
Autor:
Toru Watanabe
Publikováno v:
Breast Cancer (Tokyo, Japan)
Oral fluoropyrimidine anticancer agents (oral 5-fluorouracil [5-FU]) able to be used as chemotherapy for breast cancer include tegafur–uracil (UFT), tegafur–gimeracil–oteracil potassium (S-1), doxifluridine, and capecitabine. Since the 1980s, U
Publikováno v:
Current Breast Cancer Reports
Oncoplastic surgery is integral to all breast cancer surgeries. The use of an aesthetic approach to breast conservation or mastectomy greatly enhances the range of options that can be offered to women with breast cancer and facilitates better outomes
Autor:
Rossana Bossi, Jørn Olsen, Manhai Long, Eva Cecilie Bonefeld-Jørgensen, Stine Overvad Fredslund
Publikováno v:
Cancer Causes & Control
Bonefeld-Jørgensen, E C, Long, M, Fredslund, S O, Bossi, R & Olsen, J 2014, ' Breast cancer risk after exposure to perfluorinated compounds in Danish women : a case-control study nested in the Danish National Birth Cohort ', Cancer causes & control : CCC, vol. 25, no. 11, pp. 1439-1448 . https://doi.org/10.1007/s10552-014-0446-7
Bonefeld-Jørgensen, E C, Long, M, Fredslund, S O, Bossi, R & Olsen, J 2014, ' Breast cancer risk after exposure to perfluorinated compounds in Danish women : a case-control study nested in the Danish National Birth Cohort ', Cancer causes & control : CCC, vol. 25, no. 11, pp. 1439-1448 . https://doi.org/10.1007/s10552-014-0446-7
Objective Animal studies have indicated that perfluoroalkylated substances (PFAS) increase mammary fibroadenomas. A recent case–control study in Greenlandic Inuit women showed an association between the PFAS serum levels and breast cancer (BC) risk